Trial Profile
A phase IIb/III trial of intravenous AU-105 in pediatric and adult patients with newly diagnosed glioblastoma
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 11 Jul 2016
Price :
$35
*
At a glance
- Drugs AU 105 (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 11 Jul 2016 New trial record